I'm a bit confused by them saying the PBT guidance excludes the accounting change. They said H1 EBITDA was inflated by AASB16 by $0.7m. There has also been a $0.6m increase in Depreciation and Amortisation which I assume is mainly from the Right of Use Asset being amortised. So at the PBT line AASB16 shouldn't really be making much difference?
I can't find any mention of the actual legal costs
I'm a bit confused by them saying the PBT guidance excludes the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
-0.020(4.04%) |
Mkt cap ! $38.54M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 50.5¢ | 47.5¢ | $9.83K | 19.58K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5899 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.5¢ | 1087 | 1 |
View Market Depth
| Last trade - 15.31pm 01/10/2024 (20 minute delay) ? |
| ADA (ASX) Chart |